Search

Cookies

We use cookies to improve your experience. By continuing, you accept our use of cookies.

Technology

Zomato's Deepinder Goyal Opens Early Access for 'Temple' Wearable; First 100 Units Ready

· · 2 min read

Deepinder Goyal, founder of Zomato, has announced early access for his new 'Temple' wearable device, with the initial 100 units now ready for shipment. This innovative device, worn on the temple region, is designed to track cognitive and physical health beyond traditional fitness trackers.

Zomato founder Deepinder Goyal has officially announced the commencement of early access for his much-anticipated wearable device, 'Temple'. On May 5, Goyal confirmed that the first 100 units of the device are prepared for shipment, marking a significant step towards its public release.

Goyal stated that the company is inviting applications for early access, targeting a select group of founding users. This initial cohort is expected to include a diverse range of individuals such as athletes, scientists, founders, doctors, creators, and those deeply invested in their physical and cognitive well-being.

A New Approach to Health Tracking

The 'Temple' device distinguishes itself from conventional wrist-based wearables by being designed for wear on the temple region of the head. This specific placement is intended to provide more accurate capture of biological signals, including blood flow and skin activity, due to the thinner tissue and dense vascular structures in that area.

Positioned as a next-generation wearable, 'Temple' aims to offer insights into not just physical metrics but also cognitive performance. The company describes it as a "precision instrument" focused on enhancing training, recovery, sleep, and work performance.

Goyal's Vision and Research Link

The announcement follows Goyal's earlier teasers where he had referred to 'Temple' as "the most important wearable ever made," revealing he had been personally testing the device for over a year. The product is also closely linked to his ongoing "Gravity Ageing Hypothesis" research, which explores the monitoring of blood flow and its connection to brain health.

While the early access program signals significant progress, key details such as the device's pricing, full specifications, and wider availability timelines have not yet been disclosed to the public.

Related